Rachel Frank | executive |
Sanj Patel | executive |
Ross Moat | executive |
Mark Ragosa | executive |
Kyuwon Choi | analyst |
John Paolini | executive |
Geoffrey Meacham | analyst |
Good day and thank you for standing by, and welcome to the Kiniksa Pharmaceuticals First Quarter 2023 Earnings Conference Call. [Operator Instructions] And please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Rachel Frank, Head, Investor Relations. Please go ahead.
Thank you, operator.